from The Scientist
Volume 25 | Issue 1 | Page 47
Date: 2011-01-01
By Katherine Hyde and Paul Liu
Interfering with Cancer
Acute myeloid leukemia (AML) is a cancer of the blood-cell producing bone marrow with several subtypes, and is usually fatal within months, or even weeks, if left untreated. It is now becoming clear, however, that dysregulation of microRNAs (miRs) is not simply a side effect of the cancer; rather, it could play a mechanistic role in the development of leukemia.
Read more: Interfering with Cancer – The Scientist – Magazine of the Life Sciences http://www.the-scientist.com/article/display/57885/#ixzz19nNV34TD
Subscribe to the miRNA blog
Thank you for subscribing.
Something went wrong.
